Naciśnij | HIPRA

who we are

Naciśnij

10/18/2023 - 16:14

BIMERVAX® becomes the first COVID-19 vaccine approved by WHO

Ludzkie

07/17/2023 - 14:43

AEMPS authorizes the clinical trial to study the joint vaccination of HIPRA's COVID-19 vaccine with an influenza vaccine

Ludzkie

05/29/2023 - 08:15

AEMPS authorizes the clinical trial to study HIPRA's COVID-19 vaccine in adolescents between 12 and 17 years old

Ludzkie

04/11/2023 - 16:57

The Spanish Prime Minister defines HIPRA’s vaccine as a 'historic milestone' that reinforces the country's leadership in the European health sector

Ludzkie

03/31/2023 - 14:27

BIMERVAX® has also obtained the approval of the European Commission to be marketed

Ludzkie

03/30/2023 - 16:00

HIPRA receives positive opinion from European Medicines Agency for its BIMERVAX® COVID-19 Vaccine

Ludzkie